Conversely, consistent with the angiostatic effects of CXCL9 and CXCL10 by binding to their receptor CXCR338, we earlier reported reduced angiogenesis in LLC tumors from Cav-2 KO mice as early as day 6 after tumor cell implantation39. The gene discussed is CAV2; the disease is neoplasm.